Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Mexico - Delayed Quote • MXN Novartis AG (NVSN.MX) Follow Add holdings 2,235.00 0.00 (0.00%) As of March 20 at 12:10:52 PM CST. Market Open. Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for NVSN.MX 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: NVSN.MX View More All News Press Releases SEC Filings Stocks to watch next week: Apple, Microsoft, Shell, HSBC, Lloyds and AstraZeneca Novartis (NVS) Unleashes $23BN Strategic Investment Masterstroke Novartis Stock Rises After Swiss Drugmaker Promises to Boost U.S. Manufacturing Swiss Drugmaker Novartis Promises to Boost U.S. Manufacturing Amid Tariff Threats Novartis to spend $23B to expand in the US Trending tickers: Apple, Advanced Micro Devices, Ford, BP and AstraZeneca Novartis receives FDA accelerated approval for Vanrafia® (atrasentan), the first and only selective endothelin A receptor antagonist for proteinuria reduction in primary IgA nephropathy (IgAN) Big Pharma Avoids Worst-Case Tariff Scenario Isomorphic raises $600M on big ambitions for AI drugmaking tech JNJ's Rybrevant-Lazcluze Combo Outshines AZN's Tagrisso in Lung Cancer Novartis appoints Karen Hale, Chief Legal and Compliance Officer, as Klaus Moosmayer, Chief Ethics, Risk & Compliance Officer, steps down from the Executive Committee of Novartis